Vol 20 No 3 (2014)
Journal of Commercial Biotechnology
Journal of Commercial Biotechnology
Subscribe
Current
Archives
Search
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Register
Login
Register
Login
Vol 20 No 3 (2014)
Published July 1, 2014
Commentary
Peter J. Pitts
Who Lost Opioids?
Requires Subscription or Fee
PDF
Debajit Borah, Amrita Kashyap Chaliha, Dhrubajyoti Gogoi, RNS Yadav
GM tea: the need of the hour to reclaim India’s leading position in the global tea market
Requires Subscription or Fee
PDF
Articles
William Bains
What makes a happy team? Data from 5 years’ entrepreneurship teaching suggests that working style is a major determinant of team contentment.
Requires Subscription or Fee
PDF
Diana Pham
Ethical, Legal, and Regulatory Issues Regarding the Study and Use of Medications in Pregnant Women
Requires Subscription or Fee
PDF
From the Classroom
Jiban Khuntia, Jahangir Karimi, Mohan Tanniru, Arlen Meyers
The University of Colorado Digital Health Consortium Initiative: A Collaborative Model of Education, Research and Service
Requires Subscription or Fee
PDF
Legal and Regulatory Updates
Stefan Michael Miller
Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies
Requires Subscription or Fee
PDF
Joanna T. Brougher, David A. Fazzolare
USPTO Guidance On Patentable Subject Matter: Impediment to Biotech Innovation?
Requires Subscription or Fee
PDF
Ewan Grist
EU Legal & Regulatory Update – June 2014
Requires Subscription or Fee
PDF
Conference Report
Karl Schmieder, Clara Andrew-Wani
Four Perspectives on Business Model Evolution in Synthetic Biology
Requires Subscription or Fee
PDF
Book Reviews
Susan Finston
India's Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing
Requires Subscription or Fee
PDF
×
Username
*
Required
Password
*
Required
Forgot your password?
Keep me logged in
Login
No account?
Register here